author_facet Yu, Ying
Flint, Alan F.
Mulliken, John B.
Wu, June K.
Bischoff, Joyce
Yu, Ying
Flint, Alan F.
Mulliken, John B.
Wu, June K.
Bischoff, Joyce
author Yu, Ying
Flint, Alan F.
Mulliken, John B.
Wu, June K.
Bischoff, Joyce
spellingShingle Yu, Ying
Flint, Alan F.
Mulliken, John B.
Wu, June K.
Bischoff, Joyce
Blood
Endothelial progenitor cells in infantile hemangioma
Cell Biology
Hematology
Immunology
Biochemistry
author_sort yu, ying
spelling Yu, Ying Flint, Alan F. Mulliken, John B. Wu, June K. Bischoff, Joyce 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2003-08-2859 <jats:title>Abstract</jats:title> <jats:p>Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45– nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR+ immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.</jats:p> Endothelial progenitor cells in infantile hemangioma Blood
doi_str_mv 10.1182/blood-2003-08-2859
facet_avail Online
Free
finc_class_facet Medizin
Chemie und Pharmazie
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAzLTA4LTI4NTk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAzLTA4LTI4NTk
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint American Society of Hematology, 2004
imprint_str_mv American Society of Hematology, 2004
issn 0006-4971
1528-0020
issn_str_mv 0006-4971
1528-0020
language English
mega_collection American Society of Hematology (CrossRef)
match_str yu2004endothelialprogenitorcellsininfantilehemangioma
publishDateSort 2004
publisher American Society of Hematology
recordtype ai
record_format ai
series Blood
source_id 49
title Endothelial progenitor cells in infantile hemangioma
title_unstemmed Endothelial progenitor cells in infantile hemangioma
title_full Endothelial progenitor cells in infantile hemangioma
title_fullStr Endothelial progenitor cells in infantile hemangioma
title_full_unstemmed Endothelial progenitor cells in infantile hemangioma
title_short Endothelial progenitor cells in infantile hemangioma
title_sort endothelial progenitor cells in infantile hemangioma
topic Cell Biology
Hematology
Immunology
Biochemistry
url http://dx.doi.org/10.1182/blood-2003-08-2859
publishDate 2004
physical 1373-1375
description <jats:title>Abstract</jats:title> <jats:p>Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45– nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR+ immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.</jats:p>
container_issue 4
container_start_page 1373
container_title Blood
container_volume 103
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348413363224584
geogr_code not assigned
last_indexed 2024-03-01T18:10:45.343Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Endothelial+progenitor+cells+in+infantile+hemangioma&rft.date=2004-02-15&genre=article&issn=1528-0020&volume=103&issue=4&spage=1373&epage=1375&pages=1373-1375&jtitle=Blood&atitle=Endothelial+progenitor+cells+in+infantile+hemangioma&aulast=Bischoff&aufirst=Joyce&rft_id=info%3Adoi%2F10.1182%2Fblood-2003-08-2859&rft.language%5B0%5D=eng
SOLR
_version_ 1792348413363224584
author Yu, Ying, Flint, Alan F., Mulliken, John B., Wu, June K., Bischoff, Joyce
author_facet Yu, Ying, Flint, Alan F., Mulliken, John B., Wu, June K., Bischoff, Joyce, Yu, Ying, Flint, Alan F., Mulliken, John B., Wu, June K., Bischoff, Joyce
author_sort yu, ying
container_issue 4
container_start_page 1373
container_title Blood
container_volume 103
description <jats:title>Abstract</jats:title> <jats:p>Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45– nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR+ immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.</jats:p>
doi_str_mv 10.1182/blood-2003-08-2859
facet_avail Online, Free
finc_class_facet Medizin, Chemie und Pharmazie, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDAzLTA4LTI4NTk
imprint American Society of Hematology, 2004
imprint_str_mv American Society of Hematology, 2004
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 0006-4971, 1528-0020
issn_str_mv 0006-4971, 1528-0020
language English
last_indexed 2024-03-01T18:10:45.343Z
match_str yu2004endothelialprogenitorcellsininfantilehemangioma
mega_collection American Society of Hematology (CrossRef)
physical 1373-1375
publishDate 2004
publishDateSort 2004
publisher American Society of Hematology
record_format ai
recordtype ai
series Blood
source_id 49
spelling Yu, Ying Flint, Alan F. Mulliken, John B. Wu, June K. Bischoff, Joyce 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2003-08-2859 <jats:title>Abstract</jats:title> <jats:p>Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45– nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR+ immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.</jats:p> Endothelial progenitor cells in infantile hemangioma Blood
spellingShingle Yu, Ying, Flint, Alan F., Mulliken, John B., Wu, June K., Bischoff, Joyce, Blood, Endothelial progenitor cells in infantile hemangioma, Cell Biology, Hematology, Immunology, Biochemistry
title Endothelial progenitor cells in infantile hemangioma
title_full Endothelial progenitor cells in infantile hemangioma
title_fullStr Endothelial progenitor cells in infantile hemangioma
title_full_unstemmed Endothelial progenitor cells in infantile hemangioma
title_short Endothelial progenitor cells in infantile hemangioma
title_sort endothelial progenitor cells in infantile hemangioma
title_unstemmed Endothelial progenitor cells in infantile hemangioma
topic Cell Biology, Hematology, Immunology, Biochemistry
url http://dx.doi.org/10.1182/blood-2003-08-2859